海思科(002653.SZ)子公司获得《药品GMP证书》
格隆汇12月4日丨海思科(002653.SZ)公布,公司全资子公司辽宁海思科制药有限公司(“辽宁海思科”)于近日收到辽宁省药品监督管理局颁发的中华人民共和国《药品GMP证书》。
按照国家食品药品监督管理局《药品生产质量管理规范认证管理办法》的规定,经审查,辽宁海思科的大容量注射剂(含多层共挤输液袋)(601车间)符合中华人民共和国《药品生产质量管理规范》要求,特发《药品GMP证书》,有效期至:2024年11月28日。
此次获得《药品GMP证书》,标志着辽宁海思科位于沈阳的生产基地可以正式生产和销售复方氨基酸注射液(18AA-VII),缓解原生产地址产能不足问题,将对公司未来生产经营产生积极影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.